Moderna’s COVID-19 and Zika patent applications to be investigated

08-09-2020

Muireann Bolger

Moderna’s COVID-19 and Zika patent applications to be investigated

siam.pukkato / Shutterstock.com

A US Department of Health and Human Services agency will investigate whether biopharmaceutical company, Moderna Therapeutics, fully disclosed information on government funding in patent applications relating to its COVID-19 vaccine candidate and its work on a Zika vaccine.


Moderna, COVID-19, Zika, patent, applications, BARDA, DARPA, Knowledge Ecology international, USPTO

LSIPR